Transition-state analogs as inhibitors of human and malarial hypoxanthine-guanine phosphoribosyltransferases. |
| |
Authors: | C M Li P C Tyler R H Furneaux G Kicska Y Xu C Grubmeyer M E Girvin V L Schramm |
| |
Affiliation: | Department of Biochemistry, Albert Einstein College of Medicine, Bronx, New York 10461, USA. |
| |
Abstract: | The proposed transition state for hypoxanthine-guanine phosphoribosyltransferases (HGPRTs) has been used to design and synthesize powerful inhibitors that contain features of the transition state. The iminoribitols (1S)-1-(9-deazahypoxanthin-9-yl)-1,4-dideoxy-1,4-imino-D-ribitol 5-phosphate (immucillinHP) and (1S)-1-(9-deazaguanin-9-yl)-1,4-dideoxy-1,4-imino-D-ribitol 5-phosphate (immucillinGP) are the most powerful inhibitors yet reported for both human and malarial HGPRTs. Equilibrium binding constants are >1,000-fold tighter than the binding of the nucleotide substrate. The NMR spectrum of malaria HGXPRT in the Michaelis complex reveals downfield hydrogen-bonded protons. The chemical shifts move farther downfield with bound inhibitor. The inhibitors are lead compounds for species-specific antibiotics against parasitic protozoa. The high-resolution crystal structure of human HGPRT with immucillinGP is reported in the companion paper. |
| |
Keywords: | |
|
|